comparemela.com

Eugenia Kasza News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

(Reuters) -GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 lawsuits claiming that heartburn drug Zantac causes cancer to go forward. If Judge Vivian Medinilla of Delaware Superior Court grants the petition, which is also joined by Pfizer, Sanofi and Boehringer Ingelheim, the appeal will go directly to the Delaware Supreme Court. If she denies it, GSK said, the companies will ask the Supreme Court directly to hear the case.

Latest trial over Zantac cancer claims called off | Honolulu Star-Advertiser

Latest trial over Zantac cancer claims called off | Honolulu Star-Advertiser
staradvertiser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from staradvertiser.com Daily Mail and Mail on Sunday newspapers.

Drugmakers Seek Appeal in Zantac Cancer Lawsuits

Major pharmaceutical companies, including GSK, Pfizer, Sanofi, and Boehringer Ingelheim, are seeking permission from a Delaware court to appeal a ruling that allows over 70,000 lawsuits claiming that the heartburn drug Zantac causes cancer to proceed. The companies argue against the admissibility of expert testimony linking Zantac to cancer.

Latest trial over Zantac cancer claims called off as plaintiff drops case

A woman who claimed in a lawsuit that GSK s discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the.

Latest trial over Zantac cancer claims called off as plaintiff drops case

Latest trial over Zantac cancer claims called off as plaintiff drops case
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.